BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36893511)

  • 1. Prevalence of cannabis use disorder among individuals using medical cannabis at admission to inpatient treatment for substance use disorders.
    N S Gendy M; Taisir R; Sousa S; Costello J; Rush B; Busse JW; Mackillop J
    Addict Behav; 2023 Jul; 142():107667. PubMed ID: 36893511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition.
    Mills L; Lintzeris N; O'Malley M; Arnold JC; McGregor IS
    Drug Alcohol Rev; 2022 Jul; 41(5):1095-1108. PubMed ID: 35172040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
    Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
    JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
    Fink DS; Shmulewitz D; Mannes ZL; Stohl M; Livne O; Wall M; Hasin DS
    J Psychiatr Res; 2022 Nov; 155():387-394. PubMed ID: 36182768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.
    Mauro PM; Gutkind S; Askari MS; Hasin DS; Samples H; Mauro CM; Annunziato EM; Boustead AE; Martins SS
    Drug Alcohol Depend; 2024 Apr; 257():111113. PubMed ID: 38382162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
    Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
    JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.
    Matson TE; Williams EC; Lapham GT; Oliver M; Hallgren KA; Bradley KA
    Drug Alcohol Depend; 2023 Oct; 251():110946. PubMed ID: 37688980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample.
    Rubin-Kahana DS; Hassan AN; Sanches M; Le Foll B
    Front Psychiatry; 2022; 13():836908. PubMed ID: 35432009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis.
    Froude AM; Fawcett EJ; Coles A; Drakes DH; Harris N; Fawcett JM
    J Psychiatr Res; 2024 Apr; 172():391-401. PubMed ID: 38452637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Use and its Association with Psychological Disorders.
    Urits I; Gress K; Charipova K; Li N; Berger AA; Cornett EM; Hasoon J; Kassem H; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2020 May; 50(2):56-67. PubMed ID: 32508368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis.
    Mondal A; Dadana S; Parmar P; Mylavarapu M; Dong Q; Butt SR; Kali A; Bollu B; Desai R
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.
    Livingston NA; Farmer SL; Mahoney CT; Marx BP; Keane TM
    Psychol Addict Behav; 2022 Mar; 36(2):131-143. PubMed ID: 34351175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults.
    Mennis J; McKeon TP; Stahler GJ
    Addict Behav; 2023 Mar; 138():107552. PubMed ID: 36413909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.
    Shmulewitz D; Budney AJ; Borodovsky JT; Bujno JM; Walsh CA; Struble CA; Livne O; Habib MI; Aharonovich E; Hasin DS
    J Psychiatr Res; 2023 Jul; 163():211-221. PubMed ID: 37224773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy.
    Meinhofer A; Hinde JM; Keyes KM; Lugo-Candelas C
    JAMA Psychiatry; 2022 Jan; 79(1):50-58. PubMed ID: 34730782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
    Patel RS; Goyal H; Satodiya R; Tankersley WE
    Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and correlates of cannabis use among individuals with DSM-5 social anxiety disorder: Findings from a nationally representative sample.
    Patel TA; Schubert FT; Zech JM; Cougle JR
    J Psychiatr Res; 2023 Jul; 163():406-412. PubMed ID: 37276644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.
    Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS
    Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.